Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorErol, Adnan
dc.date.accessioned2022-05-11T14:39:51Z
dc.date.available2022-05-11T14:39:51Z
dc.date.issued2009
dc.identifier.issn1387-2877
dc.identifier.urihttps://doi.org/10.3233/JAD-2009-1047
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8759
dc.description.abstractPeripheral insulin resistance is associated with hyperinsulinemia, which may be associated with brain insulin deficiency that is characteristic of sporadic Alzheimer's disease (sAD). Oxidative insult, which is the result of insulin associated disordered brain energy metabolism, is a significant early event in the pathological cascade of sAD. Aggregation of disease-specific proteins such as amyloid-? and tau may act as a compensatory response against the oxidative insult at the early periods. In the later stages, oxidative stress stimulates c-Jun N-terminal kinase (JNK) activation. The deficient insulin signaling is ultimately linked to protein kinase B (Akt) pathway and subsequently glycogen synthase kinase-3 (GSK3) and forkhead transcription factors (FOXO). Peripheral insulin resistance related intense interactions between JNK, GSK3, FOXO factors, and p53, which may lead to apoptotic neuronal death, are outlined in a postulate. In light of this postulate, the importance of detailed knowledge of these common physiological processes for the opportunities of treatment that could prevent or reduce the onset of sAD is discussed as well. © 2009 - IOS Press and the authors. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherIOS Pressen_US
dc.identifier.doi10.3233/JAD-2009-1047
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAlzheimer's diseaseen_US
dc.subjectFOXOen_US
dc.subjectGSK3en_US
dc.subjectInsulin resistanceen_US
dc.subjectJNKen_US
dc.subjectP53en_US
dc.subjectamyloid beta proteinen_US
dc.subjectforkhead transcription factoren_US
dc.subjectglycogen synthase kinase 3en_US
dc.subjectinsulinen_US
dc.subjectprotein kinase Ben_US
dc.subjectprotein p53en_US
dc.subjectstress activated protein kinaseen_US
dc.subjecttau proteinen_US
dc.subjectAlzheimer diseaseen_US
dc.subjectapoptosisen_US
dc.subjectbrain metabolismen_US
dc.subjecthyperinsulinemiaen_US
dc.subjectinsulin deficiencyen_US
dc.subjectinsulin resistanceen_US
dc.subjectmetabolic disorderen_US
dc.subjectoxidative stressen_US
dc.subjectpriority journalen_US
dc.subjectprotein aggregationen_US
dc.subjectreviewen_US
dc.titleUnraveling the molecular mechanisms behind the metabolic basis of sporadic alzheimer's diseaseen_US
dc.typereviewen_US
dc.relation.ispartofJournal of Alzheimer's Diseaseen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.identifier.volume17en_US
dc.identifier.issue2en_US
dc.identifier.startpage267en_US
dc.identifier.endpage276en_US
dc.institutionauthorErol, Adnan
dc.relation.publicationcategoryDiğeren_US
dc.authorscopusid57211151450
dc.identifier.scopus2-s2.0-67849110363en_US
dc.identifier.pmid19221404en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster